Literature DB >> 17849364

Abnormal chaperone-mediated autophagy (CMA) in cardiomyocytes of a boy with Danon disease.

Anna Fidziańska1, Ewa Walczak, Michał Walski.   

Abstract

Ultrastructural analysis of the cardiomyocyte structure in Danon disease reveals dramatic accumulation of abnormal late autophagic vacuoles (AVd) suggestive of primary lysosomal defect. Moreover, the accumulation of AVd in cardiomyocytes is consistent with a decreased rate of autophagic to lysosomal trafficking. These results suggest that the loss of the LAMP-2 protein strongly inhibits uptake of proteins into lysosomes for degeneration. The significant reduction of chaperone-mediated autophagy (CMA) activity in the affected cardiomyocytes induces a dramatic increase in the number and size of AVd and a severe reduction of myocardial contractility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17849364

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  8 in total

Review 1.  Chaperone-mediated autophagy: machinery, regulation and biological consequences.

Authors:  Wenming Li; Qian Yang; Zixu Mao
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

Review 2.  The coming of age of chaperone-mediated autophagy.

Authors:  Susmita Kaushik; Ana Maria Cuervo
Journal:  Nat Rev Mol Cell Biol       Date:  2018-06       Impact factor: 94.444

Review 3.  Dysfunction of chaperone-mediated autophagy in human diseases.

Authors:  Zhaozhong Liao; Bin Wang; Wenjing Liu; Qian Xu; Lin Hou; Jinlian Song; Qingming Guo; Ning Li
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

Review 4.  Links between autophagy and disorders of glycogen metabolism - Perspectives on pathogenesis and possible treatments.

Authors:  Benjamin L Farah; Paul M Yen; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2019-11-21       Impact factor: 4.797

Review 5.  Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises.

Authors:  Fedah E Mohamed; Lihadh Al-Gazali; Fatma Al-Jasmi; Bassam R Ali
Journal:  Front Pharmacol       Date:  2017-07-07       Impact factor: 5.810

Review 6.  Lysosomes as a therapeutic target.

Authors:  Srinivasa Reddy Bonam; Fengjuan Wang; Sylviane Muller
Journal:  Nat Rev Drug Discov       Date:  2019-09-02       Impact factor: 84.694

Review 7.  Lysosome-Targeting Strategy Using Polypeptides and Chimeric Molecules.

Authors:  Basudeb Mondal; Tahiti Dutta; Abinash Padhy; Sabyasachi Das; Sayam Sen Gupta
Journal:  ACS Omega       Date:  2021-12-22

Review 8.  The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.

Authors:  Frances M Platt; Barry Boland; Aarnoud C van der Spoel
Journal:  J Cell Biol       Date:  2012-11-26       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.